Ligand Pharmaceuticals Incorporated logo

Ligand Pharmaceuticals Incorporated

Sector: 
Healthcare
   

Industry: 
Biotechnology

97.13
 
USD
  
-0.40
  
(-0.41%)
Optionable: Yes  Market Cap: 1,555 M  90-day average vol: 0

Previous close: 97.53  Open: 96.36  Bid: 110.45  Ask: 110.45
52 week range    
0.00   
   0.00
Peers   
AMGN / 
SPPI / 
GSK / 
MRK / 
PFE / 
LLY / 
BMY / 
BAX / 
Last updated: Monday 8th August 2022

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

AMGN

0.0347129 B23.4223.53

BAX

0.012943 B35.986.87

BMY

0.0332145 B-27.366.19

GSK

JNJ

0.0247450 B22.1171.06

LLY

0.0161238 B37.4243.55

MRK

0.0356207 B28.877.58

PFE

0.0302298 B15.153.21

SPPI

0 B-0.70.6707
Chart
News
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 15.63


Financials

LGND Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues31 M49 M65 M72 M109 M141 M251 M120 M186 M277 M
Cost of sales8740003 M6 M3 M-7 M-6 M-2 M-22 M-4 M7 M
Gross operating profit28 M43 M56 M66 M104 M135 M244 M109 M161 M219 M
Selling Gen & administrative expense16 M18 M23 M25 M28 M29 M38 M42 M64 M20 M
Research & development expense11 M9 M10 M11 M21 M27 M28 M56 M59 M69 M
Operating income1 M16 M21 M27 M44 M68 M164 M-6 M9 M79 M
floaterest income0000000000
floaterest expense0000000000
Other income net-2 M-5 M-5 M20 M-24 M55500044 M810 M73000-13 M
Pre-tax Income (EBT)-4 M9 M11 M35 M8 M57 M173 M797 M-11 M47 M
Income taxes-1 M374000410000-192 M10 M45 M30 M167 M-8 M-10 M
Net income from total operations-52700011 M11 M227 M-2 M13 M143 M629 M-3 M57 M
Minority floaterest0000000000
Total net income-52700011 M12 M230 M-2 M13 M143 M629 M-3 M57 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-3 M9 M11 M227 M-2 M13 M143 M629 M-3 M57 M
Depreciation3 M3 M3 M3 M12 M12 M9 M33 M29 M51 M
Amortization002 M2 M11 M12 M16 M17 M23 M47 M
Operating income before depreciation (EBITDA)4 M19 M23 M30 M32 M83 M237 M876 M45 M118 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-0.030.560.5913-0.080.66.7733.13-0.183.44
Diluted EPS total-0.030.550.5612.12-0.080.535.9631.85-0.183.31
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!